alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 20,476–20,500 of 27,380 studies, newest first · page 820 of 1096.

November 2010 16

  1. 2010-11-01

    Dementia and hip fractures: development of a pathogenic framework for understanding and studying risk

    ✓ Peer-reviewed Clinical safety Geriatric orthopaedic surgery & rehabilitation

    Key finding: Dementia and hip fractures are 2 conditions that are seen primarily in older adults, and both are associated with substantial morbidity and mortality.

    Full summary, score breakdown and related studies → Original source

  2. 2010-11-01

    Amyloid-independent mechanisms in Alzheimer's disease pathogenesis

    ✓ Peer-reviewed Disease mechanisms The Journal of neuroscience : the official journal of the Society for Neuroscience

    Key finding: The hypothesis that amyloid-β (Aβ) peptides are the primary causative agents of AD retains significant support among researchers. +1 more finding

    Full summary, score breakdown and related studies → Original source

  3. 2010-11-01

    Palliative Care for Patients with Dementia: A National Survey

    ✓ Peer-reviewed Health systems and care delivery Journal of the American Geriatrics Society

    Key finding: Ninety-four percent of hospices and 72% of PC programs had served at least one patient with a primary diagnosis of dementia within the past year. +4 more findings

    Full summary, score breakdown and related studies → Original source

  4. 2010-11-01

    A recommended scale for cognitive screening in clinical trials of Parkinson's disease

    ✓ Peer-reviewed Cognitive tests and assessment Movement disorders : official journal of the Movement Disorder Society

    Key finding: There is a critical need for a brief, standard cognitive screening measure for use in PD trials whose primary focus is not on cognition. +3 more findings

    Full summary, score breakdown and related studies → Original source

  5. 2010-11-01

    Amyloid imaging of Lewy body-associated disorders

    ✓ Peer-reviewed Mild cognitive impairment Movement disorders : official journal of the Movement Disorder Society

    Key finding: Regional PIB BPs and the proportion of individuals with abnormally elevated MCBP were not significantly different across participant groups. +2 more findings

    Full summary, score breakdown and related studies → Original source

  6. 2010-11-01

    Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin

    ✓ Peer-reviewed Lewy body dementia Neuron

    Key finding: In the CNS, Sortilin is expressed by neurons and PGRN is most strongly expressed by activated microglial cells after injury. +4 more findings

    Full summary, score breakdown and related studies → Original source

  7. 2010-11-01

    Change in plasma Aß peptides and onset of dementia in adults with Down syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's Neurology

    Key finding: Among adults with DS, decreasing levels of plasma Aβ42, a decline in the Aβ42/Aβ40 ratio, or increasing levels of Aβ40 may be sensitive indicators of conversion to AD, possibly reflecting compartmentalization of Aβ peptides in the brain. +2 more findings

    Full summary, score breakdown and related studies → Original source

  8. 2010-11-01

    YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease

    ✓ Peer-reviewed How common it is Biological psychiatry

    Key finding: These data demonstrate that YKL-40, a putative indicator of neuroinflammation, is elevated in AD and, together with Aβ42, has potential prognostic utility as a biomarker for preclinical AD. +2 more findings

    Full summary, score breakdown and related studies → Original source

  9. 2010-11-01

    Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden

    ✓ Peer-reviewed Caregiving Molecular neurodegeneration

    Key finding: Neuroprotection alone is not sufficient to rescue tau-induced memory loss in a transgenic mouse model. +2 more findings

    Full summary, score breakdown and related studies → Original source

  10. 2010-11-01

    Impact of early onset dementia on caregivers: a review

    ✓ Peer-reviewed Caregiving International journal of geriatric psychiatry

    Key finding: Whether there is a difference in impact between EOD and LOD on caregivers is still unclear. +2 more findings

    Full summary, score breakdown and related studies → Original source

  11. 2010-11-01

    Imaging correlates of pathology in corticobasal syndrome

    ✓ Peer-reviewed Brain scans and imaging Neurology

    Key finding: Imaging patterns of atrophy in CBS vary according to pathologic diagnosis. +3 more findings

    Full summary, score breakdown and related studies → Original source

  12. 2010-11-01

    Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative

    ✓ Peer-reviewed Brain scans and imaging Archives of neurology

    Key finding: White matter hyperintensity volume predicts 1-year cognitive decline in a relatively healthy convenience sample that was similar to clinical trial samples, and therefore should be considered as a covariate of interest at baseline and longitudinally in future AD treatment trials. +2 more findings

    Full summary, score breakdown and related studies → Original source

  13. 2010-11-01

    Loss of 'small-world' networks in Alzheimer's disease: graph analysis of FMRI resting-state functional connectivity

    ✓ Peer-reviewed Brain scans and imaging PloS one

    Key finding: We present evidence of AD-induced changes in global brain functional connectivity specifically affecting long-distance connectivity. +1 more finding

    Full summary, score breakdown and related studies → Original source

  14. 2010-11-01

    The MoCA: well-suited screen for cognitive impairment in Parkinson disease

    ✓ Peer-reviewed Getting a diagnosis Neurology

    Key finding: Primary outcomes using receiver operating characteristic (ROC) curve analyses showed that all 3 mental status tests produced excellent discrimination of PD-D from patients without dementia (area under the curve [AUC], 87%-91%) and PD-MCI from PD-N patients (AUC, 78%-90%), but the MoCA was generally better suited across both assessments.

    Full summary, score breakdown and related studies → Original source

  15. 2010-11-01

    Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial

    ✓ Peer-reviewed Treatments JAMA

    Key finding: Epidemiological studies suggest that consumption of DHA is associated with a reduced incidence of Alzheimer disease. +4 more findings

    Full summary, score breakdown and related studies → Original source

  16. 2010-11-01

    Insulin metabolism and the risk of Alzheimer disease: the Rotterdam Study

    ✓ Peer-reviewed Genetics Neurology

    Key finding: Our findings suggest that insulin metabolism influences the clinical manifestation of AD only within 3 years. +4 more findings

    Full summary, score breakdown and related studies → Original source

October 2010 9

  1. 2010-10-30

    Inflammation and Alzheimer's disease

    ✓ Peer-reviewed Inflammation and the immune system Archives of pharmacal research

    Key finding: It is characterized by extracellular deposition of a specific protein, beta-amyloid peptide fibrils, and is accompanied by extensive loss of neurons in the brains of affected individuals. +3 more findings

    Full summary, score breakdown and related studies → Original source

  2. 2010-10-29

    Neuropsychiatric symptoms and quality of life in patients with very mild and mild Alzheimer's disease

    ✓ Peer-reviewed Caregiving International journal of geriatric psychiatry

    Key finding: NPS are common even in the early stages of AD. +2 more findings

    Full summary, score breakdown and related studies → Original source

  3. 2010-10-28

    Review of effects of physical activity on strength, balance, mobility and ADL performance in elderly subjects with dementia

    ✓ Peer-reviewed Prevention trials Dementia and geriatric cognitive disorders

    Key finding: Multicomponent interventions can improve physical functioning and BADL in elderly subjects regardless of the stage of dementia. +1 more finding

    Full summary, score breakdown and related studies → Original source

  4. 2010-10-27

    Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normal subjects

    ✓ Peer-reviewed Genetics Neurology

    Key finding: A slower rate of hippocampal atrophy in normal APOE2 carriers is consistent with the lower risk of Alzheimer disease in these individuals. +4 more findings

    Full summary, score breakdown and related studies → Original source

  5. 2010-10-26

    Enhancing dementia care: a primary care-based memory clinic

    ✓ Peer-reviewed Clinical safety Journal of the American Geriatrics Society

    Key finding: The results indicate that memory clinics within primary care settings can support capacity building to ensure quality assessment and management of dementia at a primary care level.

    Full summary, score breakdown and related studies → Original source

  6. 2010-10-26

    β-Amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease

    ✓ Peer-reviewed Risk genes beyond APOE Free radical biology & medicine

    Key finding: The abnormal interactions of Aβ with metal ions such as iron are implicated in the process of Aβ deposition and oxidative stress in AD brains. +3 more findings

    Full summary, score breakdown and related studies → Original source

  7. 2010-10-25

    Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia

    ✓ Peer-reviewed Vascular contributions Archives of internal medicine

    Key finding: In this large cohort, heavy smoking in midlife was associated with a greater than 100% increase in risk of dementia, AD, and VaD more than 2 decades later. +4 more findings

    Full summary, score breakdown and related studies → Original source

  8. 2010-10-25

    Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies

    ✓ Peer-reviewed Cognitive tests and assessment The Lancet. Neurology

    Key finding: We investigated the effects of renin-angiotensin system blockade on cognitive function in patients aged 55 years and older with established atherosclerotic cardiovascular disease or diabetes with end-organ damage in two clinical trials. +3 more findings

    Full summary, score breakdown and related studies → Original source

  9. 2010-10-22

    Smoking Characteristics of Adults With Selected Lifetime Mental Illnesses: Results From the 2007 National Health Interview Survey

    ✓ Peer-reviewed Prevention and risk American Journal of Public Health

    Key finding: The age-adjusted smoking prevalence of adults with mental illness or serious psychological distress ranged from 34.3% (phobias or fears) to 59.1% (schizophrenia) compared with 18.3% of adults with no such illness. +4 more findings

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →